SHANGHAI, Aug. 3, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced financial results for the first half ending June 30, 2026 ("Reporting Period"). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform.

Financial Highlights

• H1 2026 total revenue reached RMB 28.90 billion, up 38.9% YoY; revenue from Continuing Operations^[2] up 48.0% YoY.
• Adjusted non-IFRS gross profit margin expanded 9.4 percentage points (pts) YoY to 53.9%.
• Adjusted non-IFRS net profit up 83.2% YoY to RMB 11.57 billion; adjusted non-IFRS net profit margin up 9.7pts YoY to 40.0%; adjusted non-IFRS diluted EPS^[3] up 78.2% YoY to RMB 3.92.
• Net profit per CAS^[4] up 29.4% YoY to RMB 11.08 billion; diluted EPS up 25.8% YoY to RMB 3.76.
• Backlog for Continuing Operations up 25.2% YoY to RMB 66.43 billion as of June 30, 2026.
• Adjusted operating cash flow rose 41.3% YoY to RMB 9.98 billion.

Management Comment

Dr. Ge Li, Chairman and CEO of WuXi AppTec, said, "As a dedicated enabler of the industry, we truly appreciate that our achievements are rooted in the exceptional performance of our customers. Driven by the greater success of multiple customers' products, our unique CRDMO model, and our global team's perseverance for excellence, we delivered strong growth across revenue, profit, and cash flow in H1 2026, with our backlog for Continuing Operations reaching RMB 66.4 billion. We have therefore raised all of our 2026 guidance metrics and further accelerated our global capacity expansion."

"Recently, the U.S. Department of Defense included the Company on its 1260H list. This erroneous designation is not supported by facts or law. We have taken legal action to protect the interests of our customers, employees, and shareholders. We believe that the facts will prevail after an objective and fair judicial review of this ongoing litigation."

"As technology advancements and science innovations continue to emerge, WuXi AppTec remains steadfast in 'doing the right thing and doing it right.' We will relentlessly enable global innovators and realize our vision that 'every drug can be made and every disease can be treated.'"

Sustainability, and Quality Compliance

WuXi AppTec maintained the highest "AAA" MSCI ESG rating in 2026. Meanwhile, the Company successfully completed 465 quality audits and inspections^[5] conducted by global customers, regulatory authorities, and independent third parties, as well as 21 information security audits by global customers in H1 2026, all with no critical findings. Twenty main sites are now ISO/IEC 27001 certified.

Shareholder Returns

The Company distributed its 2025 annual cash dividend totaling RMB 4.71 billion^[6]. Following the first interim dividend in 2025, the Board has proposed a further increase in the 2026 interim cash dividend to shareholders of RMB 5.10 per 10 shares (approximately RMB 1.5 billion in total).

2026 Full-Year Outlook

Driven by the greater success of multiple customers' products, our unique CRDMO model, and management and execution excellence, the Company has raised full-year guidance.

• 2026 total revenue target raised to RMB 58.5-60.5 billion (previously RMB 51.3-53.0 billion), with Continuing Operations revenue growing 35-39% YoY (previously 18-22%).
• The Company is confident in maintaining a stable and resilient adjusted non-IFRS net profit margin in 2026.
• 2026 capex guidance raised to RMB 7.5-8.5 billion (previously RMB 6.5-7.5 billion) to support accelerated global capacity expansion, including initiation of the new Changzhou site ahead of schedule.
• As a result, 2026 adjusted free cash flow raised to RMB 13.5-14.5 billion (previously RMB 10.5-11.5 billion).

About WuXi AppTec

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at https://www.wuxiapptec.com.

This press release provides a summary of the results and does not intend to provide a complete statement relating to the Company, its securities, or any relevant matters herein that a recipient may need in order to evaluate the Company. For relevant information, please refer to the Company's disclosure documents and information on the Shanghai Stock Exchange ("SSE"), the Stock Exchange of Hong Kong Limited ("HKEX") and the Company's website. Investors are advised to exercise caution and be aware of the investment risks in trading Company shares.

Unless otherwise stated, all financials disclosed in this press release are prepared based on IFRS. The currency is RMB.

The 2026 Interim Report of the Company has not been audited.

Forward-Looking Statements

This press release may contain certain statements that are or may be forward looking, which can be recognized by the use of words such as "expects", "plans", "will", "estimates", "projects", "intends", or words of similar meaning. Such forward-looking statements are not historical facts, but instead are predictions about future events based on our beliefs, development strategy, business plan as well as assumptions made by and information currently available to our management. Although we believe that our predictions are reasonable, future events are inherently uncertain and our forward-looking statements may turn out to be incorrect. Our forward-looking statements are subject to risks and uncertainties including, but not limited to, the effective competitiveness of our services, our ability to meet timelines for the expansion of our service offerings or to reach the scale of our production capacity expansion plans, our ability to protect our clients' intellectual property, industry competition and regulation, the international geopolitical environment, legislative restrictions and judicial proceedings, the impact of emergencies and other force majeure. Our forward-looking statements do not constitute any profit forecast by our management or an undertaking by WuXi AppTec Co., Ltd. ("WuXi AppTec" or the "Company") to our investors. ACCORDINGLY, YOU ARE STRONGLY CAUTIONED THAT RELIANCE ON ANY FORWARD-LOOKING STATEMENTS INVOLVES KNOWN AND UNKNOWN RISKS AND UNCERTAINTIES. All forward-looking statements contained herein are qualified by reference to the cautionary statements set forth in this section. All information provided in this press release is as of the date of this press release and is based on assumptions that we believe to be reasonable as of this date, and we do not undertake any obligation to update any forward-looking statement or information in this press release to reflect future events or circumstances, except as required under applicable law.

Use of Adjusted Non-IFRS Financial Measures

To supplement the Company's IFRS consolidated financial statements, we also provide adjusted non-IFRS gross profit, adjusted non-IFRS net profit attributable to the owners of the Company ("Adjusted Non-IFRS Net Profit"), adjusted non-IFRS diluted earnings per share ("Adjusted Non-IFRS Diluted EPS"), adjusted operating cash flow and adjusted free cash flow. These measures are not required by, or presented in accordance with IFRS.

We believe that the adjusted non-IFRS financial measures used in this press release are useful for understanding and assessing our core business performance and operating trends, and we believe that management and investors may benefit from referring to these measures in assessing our financial performance by eliminating the impact of certain unusual, non-recurring, non-cash and non-operating items that we do not consider indicative of the performance of our core business. The management of the Company believes such adjusted non-IFRS financial measures are widely accepted and adopted in the industry in which the Company operates. However, the presentation of these adjusted non-IFRS financial measures is not intended to be considered in isolation, or as a substitute for the financial information prepared and presented in accordance with IFRS. You should not view adjusted results on a stand-alone basis or as a substitute for results under IFRS, or as being comparable to results reported or forecasted by other companies.

The HSI opened 102 pts higher before briefly turning south, but later regained upward momentum. It closed the day at 26,009, up 124 pts or 0.48%, with full-day turnover reaching HKD255.179 billion. The HSTECH closed at 4,875, up 46 pts or 0.96%, while the HSCEI closed at 8,652, up 40 pts or 0.46%.

Dotcom bellwethers drove the broader market higher. BABA-W (09988.HK) had a good run, closing at HKD125.2, up 7.01%, after launching the Qwen 3.8-Max AI model, with performance comparable to Anthropic Fable. TENCENT (00700.HK), BIDU-SW (09888.HK) and KUAISHOU-W (01024.HK) soared more than 3%. JD-SW (09618.HK) and MEITUAN-W (03690.HK) gained more than 1%. XIAOMI-W (01810.HK) bucked the trend, down 2.85%, after announcing price increases of up to RMB500 for premium smartphone models. UBS lowered its TP on the company, citing persistently high memory costs and weak end-market demand.

China's State Administration for Market Regulation (SAMR) launched price compliance guidance for the photovoltaic industry, boosting solar stocks. XINYI SOLAR (00968.HK) was the best-performing blue chip of the day, jumping up 13.41%. Following its results announcement, Citi upgraded the stock to Buy. GCL TECH (03800.HK) spiked 11.48%, while FLAT GLASS (06865.HK) climbed 11.22%.

Autos were in a mixed bag. LI AUTO-W (02015.HK) fell off 2.92%, while GEELY AUTO (00175.HK) declined 1.11%. BYD COMPANY (01211.HK) edged up 0.8%. Metal and resource stocks came under pressure, with CHINAHONGQIAO (01378.HK) retreating 6.44% and CHALCO (02600.HK) dropping 2.36%. PETROCHINA (00857.HK) and SINOPEC CORP (00386.HK) both lost more than 1%.
~

AASTOCKS Financial News
Website: www.aastocks.com

UBS published a research report covering Amazon.com, Inc. (AMZN.US), of which cloud service AWS recorded AI ARR of USD25 billion in 2FQ, while backlog added to USD496 billion, reflecting synchronized acceleration in enterprise demand for Bedrock and core services.

Excluding approximately USD600 million in energy cost benefits, AWS operating margin remained flat QoQ at 38%. UBS expected Amazon.com, Inc.'s operating margin to continue expanding through 2027, while the market will continue narrowing the gap between its revenue and operating profit forecasts, ultimately driving a re-rating of the share price.

The broker reiterated its Buy rating on Amazon.com, Inc. and raised the TP from USD305 to USD318.
~

AASTOCKS Financial News
Website: www.aastocks.com

CMSI said in a report that cloud business growth in the US internet sector has returned to an upward trajectory, while fundamentals of core businesses remain solid. Returns from AI investment are being realized through incremental cloud backlog orders and gains from equity investments.

The report said overall free cash flow in the sector remains under pressure, while capital expenditure guidance has diverged. Meta Platforms, Inc. (META.US) has become more cautious in its investment pace and is shifting toward enterprise AI business deployment, while the other three tech giants continue to signal increased investment.

Growth at the three major cloud platforms accelerated again, and AI investment has begun converting into revenue and order backlog. The broker remains positive on the US internet sector, with stock preference ranking unchanged: Meta Platforms, Inc. (META.US) > Alphabet Inc. (GOOGL.US) > Amazon.com, Inc. (AMZN.US) > Microsoft Corporation (MSFT.US).
~

AASTOCKS Financial News
Website: www.aastocks.com

MINIMAX-W (00100.HK)'s H3 model was open-sourced today (3rd). Huawei Ascend, MOORE THREADS (688795.SH), METAX (688802.SH), HYGON INFORMATION (688041.SH), Kunlunxin, ILUVATAR COREX (09903.HK), BIREN TECH (06082.HK), Advanced Micro Devices, Inc. (AMD.US), Intel Corporation (INTC.US), as well as Hugging Face, ModelScope and ComfyUI were among the 16-tier chipmakers, developer communities and cloud inference platforms that completed relevant compatibility support on the same day as the H3 open-source release.

MiniMax H3 is a general-purpose full-modality generation system. It ranks first globally in video editing capability on the Artificial Analysis leaderboard. The system can uniformly understand multimodal contexts comprising text, images, videos and audio, and can generate videos with up to 2K resolution, a maximum length of 15 seconds, and native stereo audio.

A relevant person in charge at MiniMax said the company will continue building more open, versatile and intelligent models, while working with partners to jointly foster a thriving open-source ecosystem.

MINIMAX-W leapfrogged 11.4% at one point to a peak of HKD256.8. It last reported at HKD247.6, up 7.37%, with trading volume of 6.3924 million shares, involving turnover of HKD1.582 billion.
~

AASTOCKS Financial News
Website: www.aastocks.com

HONG KONG, Aug. 3, 2026 /PRNewswire/ -- Hong Kong Exchanges and Clearing Limited (HKEX) is pleased to announce today (Monday) the launch of its Five-Year China Government Bond (CGB) Futures contract, marking a significant step forward in the development of Hong Kong's fixed-income and currencies (FIC) ecosystem and further enriching the city's offshore Renminbi (RMB) market.

HKEX also warmly welcomes the measures announced by Wu Qing, Chairman of the China Securities Regulatory Commission, to deepen cooperation and connectivity between the Chinese Mainland and Hong Kong financial markets, and supporting the continued development of Hong Kong as an international financial centre.

HKEX held a launch ceremony at HKEX Connect Hall today, bringing together senior representatives from regulatory agencies, financial infrastructure institutions, market participants and industry stakeholders to celebrate the product launch.

For HKEX, the new CGB Futures contract expands its growing China-related product suite and complements existing mutual market access programmes, including Bond Connect and Swap Connect. As the only CGB futures contract available in the offshore market, this on-exchange listed instrument enhances investors' ability to manage duration and interest-rate exposure to the Chinese Mainland bond market.

HKEX Chairman, Carlson Tong, said: "A vibrant FIC market is critical to Hong Kong's future growth as an international financial centre. As global investors increase their participation in Asia's bond and RMB markets, Hong Kong has an important role to play as a trusted, open and connected hub that links China and the world. The launch of Five-Year China Government Bond Futures further strengthens Hong Kong's offshore RMB product suite, supports the continued internationalisation of the currency, and reinforces the city's position as a comprehensive platform for capital formation, trading and risk management."

HKEX Chief Executive Officer, Bonnie Y Chan, said: "We are delighted to see the launch of Five-Year China Government Bond Futures today, marking a key milestone as HKEX delivers on its strategic imperative to develop a more diversified, multi-asset marketplace. From Bond Connect and Swap Connect to our growing derivatives, commodities and FIC offerings, we are creating a more integrated ecosystem that enables investors to allocate capital, manage risk and access new opportunities. Looking ahead, we will be working closely with regulators, infrastructure partners and market participants to expand connectivity, broaden product choice and strengthen risk-management capabilities across asset classes."

The CGB Futures contract's pricing benchmark is supported by ChinaBond Pricing Center Co. Ltd., which licenses bond valuation data and provides price calculation services, enhancing transparency and credibility for offshore market participants.

The SFC Commission Levy will be exempted for the first six months of trading and a market-wide trading fee discount of 50 per cent will be applied until 30 July 2027. At launch, the contract is supported by 13 liquidity providers from banks and securities firms together with extensive market participants, reflecting strong industry engagement. More details about the Five-Year CGB Futures are available on the HKEX website.

About HKEX

Hong Kong Exchanges and Clearing Limited (HKEX) is a publicly-traded company (HKEX Stock Code: 388) and one of the world's leading global exchange groups, offering a range of equity, derivative, commodity, fixed income and other financial markets, products and services, including the London Metal Exchange.

As a superconnector and gateway between East and West, HKEX facilitates the two-way flow of capital, ideas and dialogue between China and the rest of the world, through its pioneering Connect schemes, increasingly diversified product ecosystem and its deep, liquid and international markets.

HKEX is a purpose-led organisation which, across its business and through the work of HKEX Foundation, seeks to connect, promote and progress its markets and the communities it supports for the prosperity of all.

www.hkexgroup.com 

At midday, the HSI concluded at 25,895, up 11 pts or 0.04%, with turnover at HKD142.699 billion. The HSTECH closed the half-day at 4,864, up 35 pts or 0.74%. The HSCEI stood at 8,622, up 10 pts or 0.13%.

Among active leading techs, BABA-W (09988.HK) elevated 6.75% after launching its Qwen 3.8-Max AI model, with performance comparable to Anthropic Fable. BIDU-SW (09888.HK) soared 3.87%. TENCENT (00700.HK) and KUAISHOU-W (01024.HK) rallied nearly 3%. JD-SW (09618.HK) and MEITUAN-W (03690.HK) advanced more than 1%. XIAOMI-W (01810.HK) cratered 3.68% by midday after announcing price hikes of up to RMB500 for its premium smartphone models. UBS trimmed its TP on the company, citing persistently high memory costs and weak end-market demand.

Among blue chips, XINYI SOLAR (00968.HK) was upgraded to Buy by Citi after its results announcement, with shares soaring 9.32%, making it the best-performing blue chip at midday. XINYI GLASS (00868.HK) rallied 2.36% after reporting a 17% increase in interim profit. HSBC HOLDINGS (00005.HK), which will announce results tomorrow, dipped 0.95%. SMIC (00981.HK) dropped 1.5%. CHINAHONGQIAO (01378.HK) slumped 6.52%, making it the worst-performing blue chip at midday. Macau's July GGR declined for a second consecutive month, sending SANDS CHINA LTD (01928.HK) and GALAXY ENT (00027.HK) down more than 2%.

Among AI-related stocks, MINIMAX-W (00100.HK) soared 8.07% after Citi praised the significant cost advantage of its H3 video model. Z.AI (02513.HK) lost 7.9%. XUNCE (03317.HK) swelled 14.3% after forecasting an interim turnaround to a profit of RMB72.51 million.
~

AASTOCKS Financial News
Website: www.aastocks.com

CXMT (688825.SH)'s sixth-generation low-power double data rate memory standard (LPDDR6) is nearing the end of its R&D validation stage, marking an important step before mass production, according to a report by China Business Network citing sources.

As early as March 2026, market sources divulged that CXMT was actively advancing the commercialization of LPDDR6 products and had already provided samples to core customers. The products are expected to be launched and enter mass production in 2H26.

In addition, SK hynix Inc. (SKHY.US) has recently finalized its LPDDR6 mass production plan, while XIAOMI-W (01810.HK) is expected to become one of the first manufacturers to adopt the memory in flagship smartphone models, report told.
~

AASTOCKS Financial News
Website: www.aastocks.com

Moonshot AI reached a computing power agreement with BABA-W (09988.HK), allowing it to use about 20,000 Nvidia (NVDA.US) chips, Bloomberg, citing sources, reported.

The chips reportedly obtained by Moonshot AI through BABA-W came from Nvidia's earlier-generation Hopper product, the H200 chip, although BABA-W denied the claim.

A spokesperson for BABA-W said reports that the company supplied H200 chips to Moonshot AI were completely groundless, but did not deny providing related Nvidia chip computing power to Moonshot AI, and also declined to disclose the actual chip model used.
~

AASTOCKS Financial News
Website: www.aastocks.com

CONCORD NE (00182.HK) gapped up 14.08% at the open today (3rd), reaching a peak of HKD0.415. It last printed at HKD0.395, up 11.27%, with turnover of HKD5.9297 million.

CONCORD NE announced that the Company’s wholly owned subsidiaries in the US entered into three long-term Power Purchase Agreements (PPAs) with Tesla (TSLA.US) for solar projects in the US.

The long-term PPAs cover three solar projects with a total capacity of approximately 469 MW (AC). Upon full operation of all three projects, the Company will supply Tesla with approximately 1,200 GWh of electricity annually in the US. The first project is expected to commence power supply in the first half of 2027.
~

AASTOCKS Financial News
Website: www.aastocks.com